Allergy Therapeutics
AGY.L
#5944
Rank
A$1.37 B
Marketcap
A$0.22
Share price
0.00%
Change (1 day)
52.42%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -A$76.02 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$75.57 Million. In 2025 the company made an earning of -A$76.02 Million a decrease over its 2024 earnings that were of -A$69.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-A$76.02 Million8.65%
2024-A$69.96 Million-6.69%
2023-A$74.98 Million244.94%
2022-A$21.74 Million-404.35%
2021A$7.14 M-49.42%
2020A$14.12 M83.48%
2019A$7.69 M-159.83%
2018-A$12.87 Million255.48%
2017-A$3.62 Million-84.06%
2016-A$22.71 Million-1667.33%
2015A$1.44 M-44.68%
2014A$2.61 M130.59%
2013A$1.13 M-19.89%
2012A$1.41 M-127.05%
2011-A$5.25 Million2009.96%
2010-A$0.25 Million-99.07%
2009-A$26.62 Million-53.23%
2008-A$56.91 Million-21.86%
2007-A$72.83 Million356.94%
2006-A$15.94 Million230.75%
2005-A$4.82 Million-217.9%
2004A$4.08 M-58.79%
2003A$9.91 M-196.03%
2002-A$10.33 Million